| ²é¿´: 213 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
feiyuoo7½ð³æ (ÕýʽдÊÖ)
|
[½»Á÷]
ÇóÖúÒ»¾ä»°µÄ·Òë
|
||
| Choice of outcome measure, whether the sample was diagnosed with schizophrenia or with nonschizophrenic psychoses, study location, or study period were not significantly associated with risk estimates on subgroup or metaregression analysis. |
» ²ÂÄãϲ»¶
285Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ11È˻ظ´
µ÷¼Á
ÒѾÓÐ8È˻ظ´
¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ9È˻ظ´

mdzhao
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2850.7
- Ìû×Ó: 875
- ÔÚÏß: 11.6Сʱ
- ³æºÅ: 858600
- ×¢²á: 2009-09-28
- ÐÔ±ð: MM
- רҵ: ÐÅÏ¢×ÊÔ´¹ÜÀí
¡ï ¡ï
feiyuoo7(½ð±Ò+2,VIP+0): 11-5 08:57
feiyuoo7(½ð±Ò+2,VIP+0): 11-5 08:57
| ¸ù¾Ý½á¹ûÅжϣ¬¸Ã²¡ÀýÊôÓÚ¾«Éñ·ÖÁÑÖ¢»ònonschizophrenic¾«Éñ²¡£¬Ñо¿µØµã»òÕßÑо¿ÆÚÏÞÓëС×é·ÖÎöÆÀ¹À»òmetaregression·ÖÎöÎÞÏÔÖø¹ØÁª |
2Â¥2009-11-02 15:13:41
yjhorn
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1725.8
- Ìû×Ó: 629
- ÔÚÏß: 18.3Сʱ
- ³æºÅ: 33078
- ×¢²á: 2003-12-28
- ÐÔ±ð: GG
- רҵ: ½ðÈÚѧ
¡ï ¡ï
feiyuoo7(½ð±Ò+2,VIP+0): 11-5 08:57
feiyuoo7(½ð±Ò+2,VIP+0): 11-5 08:57
|
Choice of outcome measure, whether the sample was diagnosed with schizophrenia or with nonschizophrenic psychoses, study location, or study period were not significantly associated with risk estimates on subgroup or metaregression analysis. ²»¹Ü³éÑùÑù±¾Õï¶ÏΪ¾«Éñ·ÖÁÑÖ¢»ò·Ç¾«Éñ·ÖÁÑÖ¢µÄÆäËü¾«Éñ²¡£¬Ñ¡ÔñºÎÖÖ·½·¨ÆÀ¹ÀÕï¶Ï½á¹û£¬Ñо¿µÄ³¡Ëù»òÑо¿µÄʱ¼ä¶¼ÓëС×éµÄ·çÏÕÆÀ¹À»òÕ߻عé·ÖÎöÎÞÏÔÖø¹ØÁªÐÔ¡£ |

3Â¥2009-11-02 16:50:48
yjhorn
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1725.8
- Ìû×Ó: 629
- ÔÚÏß: 18.3Сʱ
- ³æºÅ: 33078
- ×¢²á: 2003-12-28
- ÐÔ±ð: GG
- רҵ: ½ðÈÚѧ
¸öÈ˾õµÃÕâÖÖ·Òë¸ü׼ȷһµã¡£
¡ï ¡ï
feiyuoo7(½ð±Ò+2,VIP+0):·Ç³£¸Ðл 11-5 08:57
feiyuoo7(½ð±Ò+2,VIP+0):·Ç³£¸Ðл 11-5 08:57
|
Choice of outcome measure, whether the sample was diagnosed with schizophrenia or with nonschizophrenic psychoses, study location, or study period were not significantly associated with risk estimates on subgroup or metaregression analysis. ²»¹Ü³éÑùÑù±¾Õï¶ÏΪ¾«Éñ·ÖÁÑÖ¢»ò·Ç¾«Éñ·ÖÁÑÖ¢µÄÆäËü¾«Éñ²¡£¬Ñ¡ÔñºÎÖÖ·½·¨ÆÀ¹ÀÕï¶Ï½á¹û£¬Ñо¿µÄ³¡Ëù»òÑо¿µÄʱ¼ä¶¼ÓëС×é·ÖÎö»ò»Ø¹é·ÖÎöµÄ·çÏÕÆÀ¹ÀÎÞÏÔÖø¹ØÁªÐÔ¡£ |

4Â¥2009-11-02 16:53:33














»Ø¸´´ËÂ¥